Early detection saves lives.
The earlier you find it, the better the odds.
-
can dramatically change the odds in the fight against cancer. When cancer is found before it has spread, treatment is often more effective and survival rates can be substantially higher. For example, the five-year relative survival rate for localized breast cancer is greater than 99%, compared with 32% once it has spread to distant parts of the body. For colon cancer, it’s 91% when localized versus 13% when distant, and for non-small cell lung cancer, 67% versus 12%.
Tests that bring peace of mind.
Mammogram / 3D mammogram — proven screening for breast cancer. Breast MRI can be added for certain high-risk patients, but it generally supplements rather than replaces mammography.
Colonoscopy or stool-based testing — colorectal screening can detect cancer early, and colonoscopy can actually prevent some cancers by finding and removing precancerous polyps. Average-risk screening begins at 45 under current ACS guidance.
Low-dose CT lung scan — recommended for certain people with a significant smoking history; this is different from routine whole-body CT screening.
HPV testing / cervical screening — can detect changes before cervical cancer develops, making this one of the strongest examples of screening actually preventing cancer.
PSA blood test — can help detect prostate cancer early; whether and when to use it should be an informed decision based on age and individual risk.
Genetic testing + family-history assessment — not a cancer-detection test itself, but identifying inherited risk can change which screenings someone receives and how early they begin.
Targeted MRI — extremely useful in certain high-risk situations, such as breast MRI for some women at substantially increased breast-cancer risk. But MRI isn't currently recommended as a universal cancer screening test for everyone.
Multi-cancer blood tests / “liquid biopsies” — exciting emerging technology that looks for cancer-associated signals in blood. But this needs careful positioning: NCI says effectiveness for screening asymptomatic people remains unproven, and no multi-cancer detection test is currently FDA-authorized for general cancer screening. They also do not replace established screening tests.